4. As of noon trading, DaVita HealthCare Partners ( DVA) is up $0.96 (0.9%) to $107.28 on average volume Thus far, 467,050 shares of DaVita HealthCare Partners exchanged hands as compared to its average daily volume of 1.0 million shares. The stock has ranged in price between $105.59-$107.39 after having opened the day at $106.31 as compared to the previous trading day's close of $106.32.

DaVita HealthCare Partners Inc. provides kidney dialysis services for patients suffering from chronic kidney failure, or end stage renal disease (ESRD) in the United States. DaVita HealthCare Partners has a market cap of $10.1 billion and is part of the health care sector. The company has a P/E ratio of 19.2, above the S&P 500 P/E ratio of 17.7. Shares are up 40.0% year to date as of the close of trading on Wednesday. Currently there are 9 analysts that rate DaVita HealthCare Partners a buy, no analysts rate it a sell, and 2 rate it a hold.

TheStreet Ratings rates DaVita HealthCare Partners as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, growth in earnings per share, increase in net income and solid stock price performance. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full DaVita HealthCare Partners Ratings Report now.

EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass

If you liked this article you might like

7 Stocks Under $10 Making Big Moves Higher

These 5 Stocks Are Breaking Out

5 Stocks With Big Insider Buying

Here’s A Reason aTyr Pharma (LIFE) Stock is Rising Today

5 Stocks Poised for Breakouts